Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc buy RudolfL

Start price
€64.70
22.02.20 / 50%
Target price
€82.00
14.05.20
Performance (%)
10.82%
End price
€71.70
14.05.20
Summary
This prediction ended on 14.05.20 with a price of €71.70. The BUY prediction by RudolfL finished with a performance of 10.82%. Dividends of €0.60 are taken into consideration when calculating the performance. RudolfL has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Gilead Sciences Inc -0.048% -0.048% -20.127% 15.854%
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to RudolfL what are the pros and cons of Gilead Sciences Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Undervalued
EBIT growth >5% per year expected
Cons

Comments by RudolfL for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Buy
Perf. (%) 10.82%
Target price 82.000
Change
Ends at 14.05.20

Buy mit Kursziel 82,0

In the thread Trading Gilead Sciences Inc
Prediction Buy
Perf. (%) 10.82%
Target price 82.000
Change
Ends at 14.05.20

Buy beendet

Stopped prediction by RudolfL for Gilead Sciences Inc

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.86
04.11.23
€89.00
04.12.23
-4.82%
05.12.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.89
09.01.21
€68.00
09.01.22
8.15%
30.10.21

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital